Focus On RTSM For Your Full Trial Lifecycle

In clinical trials, early speed often comes with hidden costs. This clip examines why an RTSM that launches quickly isn’t always the one that will support a study effectively over the years that follow. The conversation highlights a pattern many teams recognize: systems built in a rush often lack flexibility, struggle to adapt as protocols evolve, and require layers of support contacts who can’t meaningfully solve issues once the trial is underway.

The reality is that study startup represents a tiny fraction of a trial’s lifecycle. The real test of an RTSM comes during the long stretch of enrollment, supply management, dosing changes, and amendments that unfold post‑go‑live. Here, operational intensity multiplies — and shortcuts taken early can create persistent friction.

The clip also explores how efficient tooling and streamlined information gathering can minimize the burden on sponsors without sacrificing the rigor needed for long‑term stability. Rather than optimizing for a fast first eight weeks, the focus shifts to the other 95% of the trial, where system adaptability and strong support make the greatest impact.